Rhythm Pharmaceuticals Presents New Disease Burden Findings and Analyses of Setmelanotide Data in Children and Adolescents with Rare MC4R Pathway Diseases at ESPE 2022

Source :: GlobeNewswire. September 19, 2022
Publication Year :: 2022
Abstract: BOSTON, Sep 19, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NasdaqGM:RYTM), EQNX::TICKER_END -- CARE-BBS multi-country survey of 242 caregivers of individuals with Bardet-Biedl syndrome (BBS) provides extensive details on impact [...]

Subjects :: Medical research -- Surveys
Medicine, Experimental -- Surveys
Leptin -- Surveys
Children -- Health aspects
Weight loss -- Surveys
Banking, finance and accounting industries
Business

Tools